Trilogy Capital’s DNP Select Income Fund DNP Stock Holding History

Trilogy Capital’s Portfolio DNP Stock Details DNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5	Closed	–	–	244
2018 Q3	$0	Sell	5 -757	-99%	-$8.33K	﹤0.01%	618
2018 Q2	$8K	Buy	762 +15	+2%	+$162	﹤0.01%	314
2018 Q1	$8K	Buy	+747	New	+$7.72K	﹤0.01%	276

Other funds holding DNP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

GFPC

Global Financial Private Capital Sarasota, Florida $1.59B AUM 3.21% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Trilogy Capital's DNP Position: Q4 2018 in Review

Trilogy Capital sold out of DNP Select Income Fund (DNP) in Q4 2018, closing a stake of 5 shares.

Trilogy Capital first reported a position in DNP in Q1 2018 and held it in 3 quarters. The position peaked at $8K in Q2 2018. 190 funds tracked by Wall St. Rank hold DNP as of Q4 2018.

Trilogy Capital reported no remaining DNP Select Income Fund position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 5 DNP Select Income Fund shares in Q4 2018.
Trilogy Capital first reported a position in DNP Select Income Fund in Q1 2018 and held it in 3 quarters.
Trilogy Capital's DNP Select Income Fund position peaked at $8K in Q2 2018.
190 funds tracked by Wall St. Rank held DNP Select Income Fund as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.